Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.

Current Rheumatology Reports
Wolf-Henning Boehncke, Sandra Boehncke

Abstract

Psoriasis and psoriatic arthritis are associated with an increased cardiovascular mortality. Although the underlying pathogenesis is not yet fully understood, it is clear that these seemingly organ-specific disorders cause a systemic inflammatory burden as mirrored by elevated biomarkers in the patients' blood. Emerging evidence points toward insulin resistance and endothelial dysfunction as direct consequences; these in turn drive the process of atherosclerosis. As psoriasis and psoriatic arthritis therefore represent cardiovascular risk factors, they must be taken into account by primary care physicians when defining treatment goals for the comorbidities of the respective patients (e.g., arterial hypertension or dyslipidemia). Secondary and tertiary care physicians need to consider a more comprehensive treatment approach, including aspects of lifestyle intervention. Finally, effective long-term anti-inflammatory, disease-modifying therapy may contribute to reducing patients' cardiovascular risk.

References

Dec 1, 1994·The Journal of Clinical Investigation·U ScherrerP Nicod
Feb 6, 2002·Circulation·Subodh Verma, Todd J Anderson
Apr 17, 2004·The Journal of Investigative Dermatology·Ralf J LudwigThomas M Zollner
Feb 5, 2005·Journal of the American Academy of Dermatology·Srdjan ProdanovichRobert S Kirsner
Apr 22, 2005·The New England Journal of Medicine·Göran K Hansson
May 6, 2005·The New England Journal of Medicine·Michael P Schön, W-Henning Boehncke
May 11, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·S UcakY Altuntas
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Joel M GelfandAndrea B Troxel
Jan 17, 2007·The British Journal of Dermatology·R J LudwigW-H Boehncke
Jun 8, 2007·The British Journal of Dermatology·P GisondiG Girolomoni
Oct 6, 2007·The British Journal of Dermatology·S BoehnckeW-H Boehncke
Mar 4, 2008·Journal of the American Academy of Dermatology·Alexa B KimballUNKNOWN National Psoriasis Foundation
Mar 29, 2008·Metabolic Syndrome and Related Disorders·Paresh DandonaRajesh Garg
May 28, 2008·The British Journal of Dermatology·B StroberF Dann
Jul 22, 2008·The British Journal of Dermatology·A A CermanT Ergun
Aug 14, 2008·Annals of the Rheumatic Diseases·D D GladmanV T Farewell
Dec 9, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·Paolo GisondiGiampiero Girolomoni
Dec 10, 2008·The American Journal of Cardiology·Vincent E FriedewaldWilliam C Roberts
Jun 17, 2009·Archives of Dermatology·Srjdan ProdanovichDaniel G Federman
Jun 17, 2009·Rheumatology International·Rifat Eralp UlusoyBekir Sitki Cebeci
Dec 17, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·S CoimbraA Santos-Silva
Jan 19, 2010·BMJ : British Medical Journal·Wolf-Henning BoehnckeMichael P Schön
May 15, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·S PreyJ-P Ortonne
May 19, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·A B KimballM Augustin
Jul 10, 2010·Current Rheumatology Reports·Patrick DominguezAbrar A Qureshi
Jul 17, 2010·The British Journal of Dermatology·K AbuabaraJ M Gelfand
Sep 24, 2010·The Journal of Investigative Dermatology·Mayte Suárez-FariñasJames G Krueger
Dec 21, 2010·Archives of Dermatological Research·Sandra BoehnckeWolf-Henning Boehncke
Mar 18, 2011·Experimental Dermatology·Wolf-Henning BoehnckeBrian Kirby
Apr 5, 2011·The Canadian Journal of Cardiology·Idan RoifmanJacques Genest

❮ Previous
Next ❯

Citations

Jun 19, 2013·American Journal of Clinical Dermatology·Wolf-Henning Boehncke, Alan Menter
Oct 11, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Yong-Song Guan, Qing He
Jun 14, 2013·International Journal of Cell Biology·Jung S Byun, Kevin Gardner
Nov 28, 2013·American Journal of Clinical Dermatology·Shannon FameniniJashin J Wu
Apr 10, 2014·QJM : Monthly Journal of the Association of Physicians·Patompong UngprasertPromporn Suksaranjit
Apr 17, 2013·Clinical Rheumatology·Rosario PelusoMatteo Nicola Dario Di Minno
Sep 6, 2013·Clinical Rheumatology·Francesco UrsiniRosa Daniela Grembiale
Oct 16, 2015·The Journal of Dermatological Treatment·Patompong UngprasertCharat Thongprayoon
Aug 11, 2015·Dermatologic Therapy·Francisco Kerdel, Martin Zaiac
Jan 12, 2016·Joint, Bone, Spine : Revue Du Rhumatisme·Sara AlonsoRubén Queiro
Jul 15, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Joseph AhearnSusan Manzi
Nov 26, 2013·The British Journal of Dermatology·W H BoehnckeA B Gottlieb
Apr 17, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·A PietrzakT Lotti
Apr 9, 2013·Cytokine·Jackelyn B GoldenNicole L Ward
May 19, 2016·Expert Opinion on Pharmacotherapy·Alexander Egeberg, Lone Skov
May 13, 2017·The Journal of Dermatological Treatment·Anna BaranIwona Flisiak
Oct 19, 2017·Current Atherosclerosis Reports·Michael Garshick, James A Underberg
Aug 7, 2017·Clinical Reviews in Allergy & Immunology·Wolf-Henning Boehncke, Nicolo Costantino Brembilla
Jun 3, 2014·The Journal of Rheumatology·Wolf-Henning Boehncke
Nov 21, 2018·International Reviews of Immunology·Antonis A ManolisAntonis S Manolis
May 28, 2014·Clinical Drug Investigation·Renli TengJudith Hsia
Apr 14, 2017·Archives of Dermatological Research·N ZanderM Augustin
Nov 11, 2018·European Journal of Medical Research·D PatschanS Patschan
Feb 15, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Michael S GarshickJeffrey S Berger
Nov 6, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·L EissingM Augustin
Oct 22, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Billie K AlbaLacy M Alexander
Sep 28, 2017·Mediators of Inflammation·Sirje KaurMihkel Zilmer
Apr 2, 2017·Seminars in Arthritis and Rheumatism·Joseph F MerolaElinor A Mody

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.